Perceived Social Stigma of Cutaneous Leishmaniasis in Hubuna, Saudi Arabia

References

• Tzani M, Barrasa A, Vakali A, Georgakopoulou T, Mellou K, Pervanidou D. Surveillance data for human leishmaniasis indicate the need for a sustainable action plan for its management and control, Greece, 2004 to 2018. Euro Surveill; 2021;26(18):2000159 doi:10.2807/1560-7917.ES.2021.26.18.2000159
   PubMedGoogle Scholar
• Kassi M, Kassi M, Afghan AK, Rehman R, Kasi PM. Marring leishmaniasis: the stigmatization and the impact of cutaneous leishmaniasis in Pakistan and Afghanistan. PLoS Negl Trop Dis. 2008;2(10):e259. doi:10.1371/journal.pntd.0000259
   PubMed Web of Science ®Google Scholar
• Abuzaid AA, Abdoon AM, Aldahan MA, et al. Cutaneous leishmaniasis in Saudi Arabia: a comprehensive overview. Vector-Borne Zoonotic Dis. 2017;17(10):673–684. doi:10.1089/vbz.2017.2119
   PubMed Web of Science ®Google Scholar
• Basra MKA, Fenech R, Gatt RM, Salek MS, Finlay AY. The dermatology life quality index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159(5):997–1035. doi:10.1111/j.1365-2133.2008.08832.x
   PubMed Web of Science ®Google Scholar
• Okwor I, Uzonna J. Social and economic burden of human leishmaniasis. American JTrop Med Hyg. 2016;94(3):489. doi:10.4269/ajtmh.15-0408
   PubMed Web of Science ®Google Scholar
• Akilov OE, Khachemoune A, Hasan T. Clinical manifestations and classification of old world cutaneous leishmaniasis. Int J Dermatol. 2007;46(2):132–142. doi:10.1111/j.1365-4632.2007.03154.x
   PubMed Web of Science ®Google Scholar
• Afghan AK, Kassi M, Kasi PM, Ayub A, Kakar N, Marri SM. Clinical manifestations and distribution of cutaneous leishmaniasis in Pakistan. J Trop Med. 2011;2011. doi:10.1155/2011/359145
   PubMedGoogle Scholar
• Voorend CGN, Van Brakel WH, Cross H, Augustine V, Ebenso B. Report of the stigma research workshop for the development of scientific consensus papers and field guidelines on health-related stigma, held in Amsterdam, the Netherlands from 11–14 October 2010. Leprosy Rev. 2011;82(2):188–201. doi:10.47276/lr.82.2.188
   PubMedGoogle Scholar
• Kippax S, Stephenson N, Parker RG, Aggleton P. Between individual agency and structure in HIV prevention: understanding the middle ground of social practice. Am J Public Health. 2013;103(8):1367–1375. doi:10.2105/AJPH.2013.301301
   PubMed Web of Science ®Google Scholar
• Hu RV, Ramdas S, Nieuwkerk P, et al. Body location of “New World” cutaneous leishmaniasis lesions and its impact on the quality of life of patients in Suriname. PLoS Negl Trop Dis. 2020;14(10):e0008759. doi:10.1371/journal.pntd.0008759
   PubMed Web of Science ®Google Scholar
• Chahed MK, Bellali H, Ben Jemaa S, Bellaj T. Psychological and psychosocial consequences of zoonotic cutaneous leishmaniasis among women in Tunisia: preliminary findings from an exploratory study. PLoS Negl Trop Dis. 2016;10(10):e0005090. doi:10.1371/journal.pntd.0005090
   PubMed Web of Science ®Google Scholar
• Rafael F, Houinato D, Nubukpo P, et al. Sociocultural and psychological features of perceived stigma reported by people with epilepsy in Benin. Epilepsia. 2010;51(6):1061–1068. doi:10.1111/j.1528-1167.2009.02511.x
   PubMed Web of Science ®Google Scholar
• Galvão EL, Pedras MJ, Cota GF, Rabello A, Simões TC. How cutaneous leishmaniasis and treatment impacts in the patients’ lives: a cross-sectional study. PLoS One. 2019;14(1):e0211374. doi:10.1371/journal.pone.0211374
   PubMed Web of Science ®Google Scholar
• Bennis I, De Brouwere V, Belrhiti Z, Sahibi H, Boelaert M. Psychosocial burden of localised cutaneous Leishmaniasis: a scoping review. BMC Public Health. 2018;18:1–12. doi:10.1186/s12889-018-5260-9
   Web of Science ®Google Scholar
• Al‐Kamel MA. Leishmaniasis in Yemen: a clinicoepidemiological study of leishmaniasis in central Yemen. Int J Dermatol. 2016;55(8):849–855. doi:10.1111/ijd.13041
   PubMed Web of Science ®Google Scholar
• Al-Kamel MA. Stigmata in cutaneous leishmaniasis: historical and new evidence-based concepts. Our Dermatol. 2017;8(1):81. doi:10.7241/ourd.20171.21
   Google Scholar
• Fischer LS, Mansergh G, Lynch J, Santibanez S. Addressing disease-related stigma during infectious disease outbreaks. Disast Med Public Health Prepared. 2019;13(5–6):989–994. doi:10.1017/dmp.2018.157
   PubMed Web of Science ®Google Scholar
• Wenning B, Price H, Nuwangi H, et al. Exploring the cultural effects of gender on perceptions of cutaneous leishmaniasis: a systematic literature review. Global Health Res Poli. 2022;7(1):34. doi:10.1186/s41256-022-00266-y
   PubMedGoogle Scholar
• Wajihullah K, Zakai HA. Epidemiology, pathology and treatment of cutaneous leishmaniasis in Taif region of Saudi Arabia. Iran J Parasitol. 2014;9(3):365. doi:10.1186/1756-3305-5-51
   PubMed Web of Science ®Google Scholar
• Alzahrani MJ, Elfaki N, Abdalla YHA, Alkhadher MA, Ali MHM, Ahmed WAM. Cutaneous leishmaniasis: associated risk factors and prevention in Hubuna, Najran, Saudi Arabia. Int J Gene Med. 2023;723–731. doi:10.2147/IJGM.S401618
   PubMed Web of Science ®Google Scholar
• Elfaki N, Alzahrani M, Abdalla YHA, et al. Self-reported depression and anxiety rates among females with cutaneous leishmaniasis in Hubuna, Saudi Arabia. PeerJ. 2023;11:e15582. doi:10.7717/peerj.15582
   PubMed Web of Science ®Google Scholar
• General Authority for Statistics. Demographic Survey. Kingdom of Saudi Arabia. Riyadh 2022.
   Google Scholar
• Nik Jaafar N, Leong Bin Abdullah M, Talib N, et al. Validation of the Malay version of the explanatory model interview catalogue stigma scale among COVID-19 Survivors in Malaysia. J Health Translat Med. 2022;2022:112–120.
   Google Scholar
• Hatzenbuehler ML, Phelan JC, Link BG. Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013;103(5):813–821. doi:10.2105/AJPH.2012.301069
   PubMed Web of Science ®Google Scholar
• Ranawaka RR, Weerakoon HS, de Silva SH. The quality of life of Sri Lankan patients with cutaneous leishmaniasis. Mymensingh Med J. 2014;23(2):345–351.
   PubMedGoogle Scholar
• Reithinger R, Aadil K, Kolaczinski J, Mohsen M, Hami S. Social impact of leishmaniasis. Afghanistan. 2005;2005:1.
   Google Scholar
• Hagos B, Zerihun Z. Self-stigma’of people with cutaneous leishmaniasis the unrecognized one: what do we think; what do we know; what can we prove? Internat J Equ Health. 2023;22(1):180. doi:10.1186/s12939-023-01998-0
   PubMed Web of Science ®Google Scholar
• Ssewanyana IMB, Tibakabikoba H, Nakabugo J, Lule SA, Mugisha JFS. Physical and social burden of cutaneous leishmaniasis on the quality of life of patients in endemic communities of Uganda. BMC Public Health. 2020;20(1):1373. doi:10.1186/s12889-020-09376-z
   PubMedGoogle Scholar
• Gómez LJ, van Wijk R, van Selm L, et al. Stigma, participation restriction and mental distress in patients affected by leprosy, cutaneous leishmaniasis and Chagas disease: a pilot study in two co-endemic regions of eastern Colombia. Transact Roy Soc Trop Med Hyg. 2020;114(7):476–482. doi:10.1093/trstmh/trz132
   PubMed Web of Science ®Google Scholar
• Ramdas S, van der Geest S, Schallig HD. Nuancing stigma through ethnography: the case of cutaneous leishmaniasis in Suriname. Soc sci med. 2016;151:139–146. doi:10.1016/j.socscimed.2015.12.044
   PubMed Web of Science ®Google Scholar
• Frota da Rocha Morgado F, Kopp Xavier da Silveira EM, Pinheiro Rodrigues Do Nascimento L, et al. Psychometric assessment of the EMIC Stigma Scale for Brazilians affected by leprosy. PLoS One. 2020;15(9):e0239186. doi:10.1371/journal.pone.0239186
   PubMed Web of Science ®Google Scholar
• Garapati P, Pal B, Siddiqui NA, et al. Knowledge, stigma, health seeking behaviour and its determinants among patients with post kalaazar dermal leishmaniasis, Bihar, India. PLoS One. 2018;13(9):e0203407. doi:10.1371/journal.pone.0203407
   PubMed Web of Science ®Google Scholar
• Karimkhani C, Wanga V, Naghavi P, Dellavalle RP, Naghavi M. Global burden of cutaneous leishmaniasis. Lancet Infect Dis. 2017;17(3):264. doi:10.1016/S1473-3099(16)30217-1
   PubMed Web of Science ®Google Scholar
• Leventhal H, Nerenz DR, Steele DJ. Illness representations and coping with health threats. In: Handbook of Psychology and Health. Routledge; 2020:219–252.
   Google Scholar
• Nilforoushzadeh MA, Roohafza H, Jaffary F, Khatuni M. Comparison of quality of life in women suffering from cutaneous leishmaniasis treated with topical and systemic glucantime along with psychiatric consultation compared with the group without psychiatric consultation. J Skin Leishman. 2010;1:1.
   Google Scholar
• World Health Organization. Investing to Overcome the Global Impact of Neglected Tropical Diseases: Third WHO Report on Neglected Tropical Diseases 2015. World Health Organization; 2015.
   Google Scholar
• Pires M, Wright B, Kaye PM, da Conceição V, Churchill RC. The impact of leishmaniasis on mental health and psychosocial well-being: a systematic review. PLoS One. 2019;14(10):e0223313. doi:10.1371/journal.pone.0223313
   PubMed Web of Science ®Google Scholar
• Bennis I, Thys S, Filali H, De Brouwere V, Sahibi H, Boelaert M. Psychosocial impact of scars due to cutaneous leishmaniasis on high school students in Errachidia Province, Morocco. Infect Diseases Poverty. 2017;6:1–8. doi:10.1186/s40249-017-0267-5
   PubMed Web of Science ®Google Scholar
• Fikre H, van Henten S, van Griensven J, et al. Psychosocial effects of cutaneous leishmaniasis on patients in Northwestern Ethiopia: a qualitative study. medRxiv. 2023;2023:23297130.
   Google Scholar
• Nuwangi H, Agampodi TC, Price HP, Shepherd T, Weerakoon KG, Agampodi SB. Stigma associated with cutaneous and mucocutaneous leishmaniasis: a systematic review. PLoS Negl Trop Dis. 2023;17(12):e0011818. doi:10.1371/journal.pntd.0011818
   PubMed Web of Science ®Google Scholar